Company Profile

Axion Biosystems Inc (AKA: Axion Biosystems LLC)
Profile last edited on: 9/9/21      CAGE: 4TKX0      UEI: XCMKL76UJL15

Business Identifier: Microelectrode array (MEA) data acquisition and analysis: investigation of human heart and brain activity
Year Founded
First Award
Latest Award
Program Status
Active (Acquired)
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

1819 Peachtree Road NE Suite 350
Atlanta, GA 30309
   (404) 477-2557
Location: Single
Congr. District: 05
County: Fulton

Public Profile

In July 2021 it was announced that Axion BioSystems had been acquired (for an undisclosed amount) by the Swedish firm Summa Equity - an entity explicitly in the acquisition business. Axion BioSystems had been working in the space of microelectrode array (MEA) data acquisition and analysis. With the Maestro MEA platform, functional activity assays on neural or cardiomyocyte cell networks can be tackled on the benchtop facilitating investigations in neurotoxicology, cardiac safety, in vitro disease modeling, and drug discovery. Scalability options from 12- to 96-wells and a new automation system, Maestro APEX, meets high throughput screening needs as well as assay development and follow-up studies - all with a single system. High-throughput optogenetic stimulation (Lumos) is an available option to researchers, enabling simultaneous fine-tuned cellular control and real-time functional activity assessment. Tying this all together is AxIS, the integrated acquisition and analysis program that makes every MEA assay from experiment start to completed analysis simple and straightforward.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2019 2 NIH $1,847,624
Project Title: Microhook Nerve Tape: a Nerve Repair Coaptation Aid
2016 2 NIH $2,481,215
Project Title: A Microneedle Array System for Transcutaneous Nerve Mapping
2015 2 NIH $4,436,331
Project Title: Simultaneous Stimulation and Recording in Scalable Multielectrode Arrays
2012 2 NIH $389,404
Project Title: An Integrated Platform for in Vivo Neuromuscular Stimulation and Recording Using

Key People / Management

  Thomas J O'Brien -- President and Chief Executive Officer

  Mike Clements -- Vice President Marketing

  Stephen Deweerth -- Founder

  Jim Filippini -- Senior Vice President, Global Sales

  Swami Rajaraman -- MEMS R&D

  James Ross -- Founder and Chief Technical Officer

  David Stahl -- Vice President of Software Development

  Rika Yamazaki -- Marketing and Business Development Director,